CE and UKCA readiness

Evidence questions to answer before formal review

EU MDR UKCA Lifecycle evidence

CE and UKCA planning starts with clarity: intended purpose, software role, connectivity, users, data handled, clinical context, and how the product will be maintained after launch.

Early questions

The useful output is not a generic checklist. It is a traceable evidence model that shows why a control exists, what risk it reduces, and which artifact proves it.

Where VigilySys fits

VigilySys organizes the evidence model across cybersecurity, privacy, and usability so founders can discuss readiness with advisors, partners, and reviewers from a single structured view.

Official references

European Commission MDCG guidance library MHRA software and AI as a medical device guidance